Qube Research & Technologies LTD Dario Health Corp. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Dario Health Corp. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 4 shares of DRIO stock, worth $4. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 4
-0.0%
Holding current value
$4
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DRIO
# of Institutions
42Shares Held
8.19MCall Options Held
55.5KPut Options Held
3.3K-
Nantahala Capital Management, LLC New Canaan, CT2.39MShares$2.39 Million0.19% of portfolio
-
Appian Way Asset Management LP New York, NY1.38MShares$1.38 Million0.42% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L31.13MShares$1.13 Million0.02% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3981KShares$980,8070.12% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3512KShares$512,1750.01% of portfolio
About DarioHealth Corp.
- Ticker DRIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 23,295,000
- Market Cap $23.3M
- Description
- DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...